Home
Resources
Publications
PLGA-based Nanoparticles as Cancer Drug Delivery Systems

PLGA-based Nanoparticles as Cancer Drug Delivery Systems

Fatemeh Sadat Tabatabaei Mirakabad, Kazem Nejati-Koshki, Abolfazl Akbarzadeh, Mohammad Rahmati Yamchi, Mortaza Milani, Nosratollah Zarghami, Vahideh Zeighamian, Amirbahman Rahimzadeh, Somayeh Alimohammadi, etc.

Asian Pac J Cancer Prev. 2014;15(2):517-35.

PMID: 24568455

Abstract:

Poly (lactic-co-glycolic acid) (PLGA) is one of the most effective biodegradable polymeric nanoparticles (NPs). It has been approved by the US FDA to use in drug delivery systems due to controlled and sustained- release properties, low toxicity, and biocompatibility with tissue and cells. In the present review, the structure and properties of PLGA copolymers synthesized by ring-opening polymerization of DL-lactide and glicolide were characterized using 1H nuclear magnetic resonance spectroscopy, gel permeation chromatography, Fourier transform infrared spectroscopy and differential scanning calorimetry. Methods of preparation and characterization, various surface modifications, encapsulation of diverse anticancer drugs, active or passive tumor targeting and different release mechanisms of PLGA nanoparticles are discussed. Increasing experience in the application of PLGA nanoparticles has provided a promising future for use of these nanoparticles in cancer treatment, with high efficacy and few side effects.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
LS743143	PLGA nanoparticles			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: